Editorial on the article entitled "brigatinib efficacy and safety in patients with anaplastic lymphoma kinase (ALK)-positive nonsmall cell lung cancer in a phase I/II trial"

Ivana Sullivan, David Planchard

    Research output: Contribution to journalEditorial

    4 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)E1287-E1292
    JournalJournal of Thoracic Disease
    Volume8
    Issue number10
    DOIs
    Publication statusPublished - 1 Jan 2016

    Cite this